or Try an Advanced Search...

    Technical Analysis for NYXH - Nyxoah SA

    Grade Last Price % Change Price Change
    C 9.55 1.60% 0.15
    NYXH closed up 1.6 percent on Friday, November 1, 2024, on 21 percent of normal volume.
    Earnings due: Nov 5
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Flat
    Historical NYXH trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Fell Below 20 DMA Bearish 1.60%
    Bollinger Band Squeeze Range Contraction 1.60%
    Crossed Above 20 DMA Bullish -0.46%
    Bollinger Band Squeeze Range Contraction -0.46%
    Fell Below 20 DMA Bearish 0.95%
    Bollinger Band Squeeze Range Contraction 0.95%
    Older End-of-Day Signals for NYXH ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 22 hours ago
    Possible Inside Day about 22 hours ago
    Up 1% 1 day ago
    20 DMA Resistance 2 days ago
    Fell Below 20 DMA 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NYXH Chart by TradingView
    Basic chart:

    Profile

    Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah’s team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah’s innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Medicine Clinical Medicine Sleep Apnea Sleep Disorders Obstructive Sleep Apnea Neurostimulation Technology Osa

    Is NYXH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 9 Nyxoah SA (NYXH) Q2 2024 Earnings Call Highlights: Strategic Growth and US Market Preparations
    Oct 9 Information on the total number of voting rights and shares
    Oct 8 Nyxoah Secures $27 Million to Boost U.S. Presence
    Oct 7 Nyxoah raises $27M through its at-the-market offering
    Oct 7 Nyxoah Raises $27 Million through its At-the-Market Offering
    Sep 27 DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
    Sep 27 Publication relating to transparency notifications
    Sep 2 Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
    Aug 11 Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript
    Aug 6 Nyxoah SA (NYXH) Reports Q2 Loss, Misses Revenue Estimates
    See more NYXH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.0
    52 Week Low 4.0016
    Average Volume 75,767
    200-Day Moving Average 9.99
    50-Day Moving Average 8.83
    20-Day Moving Average 9.53
    10-Day Moving Average 9.58
    Average True Range 0.40
    RSI (14) 56.33
    ADX 25.68
    +DI 19.43
    -DI 12.58
    Chandelier Exit (Long, 3 ATRs) 8.94
    Chandelier Exit (Short, 3 ATRs) 9.69
    Upper Bollinger Bands 9.75
    Lower Bollinger Band 9.32
    Percent B (%b) 0.54
    BandWidth 4.44
    MACD Line 0.18
    MACD Signal Line 0.23
    MACD Histogram -0.055
    Fundamentals Value
    Market Cap 273.84 Million
    Num Shares 28.7 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -5.28
    Price-to-Sales 94.38
    Price-to-Book 2.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.07
    Resistance 3 (R3) 10.08 9.92 9.99
    Resistance 2 (R2) 9.92 9.78 9.91 9.96
    Resistance 1 (R1) 9.73 9.70 9.82 9.72 9.93
    Pivot Point 9.57 9.57 9.61 9.56 9.57
    Support 1 (S1) 9.38 9.43 9.48 9.38 9.17
    Support 2 (S2) 9.22 9.35 9.21 9.14
    Support 3 (S3) 9.03 9.22 9.11
    Support 4 (S4) 9.03